References
- Roubenoff R, Dellaripa P, Nadeau MR, Abad LW, Muldoon BA, Selhub J, Rosenberg IH. Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum 1997;40:718–22.
- Refsum H, Helland S, Ueland PM. Fasting plasma homocyst-eine as a sensitive parameter of antifolate effect: A study of psoriasis patients receiving low-dose methotrexate treatment. Clin Pharmacol Ther 1989;46:510–20.
- Morgan SL, Baggott JE, Lee JY, Alarcon GS. Folic acid supplemention prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrex-ate therapy for rheumatoid arthritis: Implications for cardio-vascular disease prevention. J Rheumatol 1998;25:441–6.
- Haagsma CJ, Blom HJ, van Riel PLCM, van't Hof MA, Giesendorf BAT van Oppenraaij-Emmerzaal D, et al. Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 1999;58:79–84.
- Trujillo-Martin E, Bustabad S, Ferraz I, Arteaga A, Pio A, La Laguna TG. Plasma homocysteine levels in patients with rheumatoid arthritis treated with methotrexate: Effect of folic versus folinic acid supplementation. Arthritis Rheum 2000;43 Suppl 9:342.
- van Ede AE, Laan RF, Haagsma CJ, Blom HJ, Thomas CJ, de Boo TM, van de Putte LB. Homocysteine and folate status in methotrexate treated patients with rheumatoid arthritis. Arthritis Rheum 2000;43 Suppl 9:342.
- Morgan SL, Baggott JE, Refsum H, Ueland PM. Homocysteine levels in patients with rheumatoid arthritis treated with low-dose methotrexate. Pharmacol Ther 1991;50:547–56.
- Kremer JM. Methotrexate update. Scand J Rheumatol 1996;25:341–4.
- Suzuki Y, Uehara R, Tajima C, Noguchi A, Ide M, Ichikawa Y, et al. Elevation of serum hepatic aminotransferases during treatment of rheumatoid arthritis with low-dose methotrexate. Rise factors and response to folic acid. Scand J Rheumatol 1999;28:273–81.
- Eikelboom JW, Lonn E, Genest J, Hankey G, Yusuf S. Homocysteine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999;131:363–75.
- Andersen LS, Hansen EL, Knudsen JB, Hansen GV, Hansen TM. Prospectively measured red cell folate levels in methotrex-ate treated patients with rheumatoid arthritis: Relation to withdrawal and side effects. J Rheumatol 1997;24:830–7.
- Morgan SL, Baggott JE, Vaughn WH, Austin JS, Veitch TA, Lee JY, et al. Supplementation with folic acid during metho-trexate therapy for rheumatoid arthritis. Ann Intern Med 1994;121:833–41.
- Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481–94.
- Landewé RBM, van den Borne BEEM, Breedveld FC, Dijkmans BAC. Methotrexate effects in patients with rheumat-oid arthritis with cardiovascular comorbidity. Lancet 2000;355:1616–7.
- Pettersson T, Friman C, Abrahamsson L, Nilsson B, Norberg B. Serum homocysteine and methylmalonic acid in patients with rheumatoid arthritis and cobalaminopenia. J Rheumatol 1998;25:859–63.